From October 1, 2021 to December 31, 2021, the company has repurchased 20,452 shares, representing 0.17% for KRW 2,279.19 million. With this, the company has completed the repurchase of 110,665 shares, representing 0.93% for KRW 14,904.82 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100,000 KRW | -0.50% | -4.03% | -23.61% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.61% | 938M | |
+18.71% | 44.35B | |
+19.44% | 15.08B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-10.43% | 6.75B | |
-8.87% | 5.73B | |
+12.55% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.